Multiple primary melanoma: Two-year results from a population-based study

Archives of Dermatology

Volumn 142, Issue 4, 2006, Pages 433-438

  Titus Ernstoff, Linda ^a,b,c   Perry, Ann E ^b   Spencer, Steven K ^b   Gibson, Jennifer ^a   Ding, Jiao ^a   Cole, Bernard ^a   Ernstoff, Marc S ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c NORRIS COTTON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLISTER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RISK; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MELANOMA; MULTIPLE CANCER; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SUNBURN; CASE CONTROL STUDY; MEDICAL RECORD; MIDDLE AGED; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; SECOND CANCER; SKIN TUMOR; TUMOR RECURRENCE; UNITED STATES;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; NEW HAMPSHIRE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS;

EID: 33646085107     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.4.433     Document Type: Article

References (25)

1. Beardmore GL, Davis NC. Multiple primary cutaneous melanomas. Arch Dermatol. 1975;111:603-609.
2. Bhatia S, Estrada-Batres L, Maryon T, Bogue M, Chu D. Second primary tumors in patients with malignant melanoma. Cancer. 1999;86:2014-2020.
3. DiFronzo LA, Wanek LA, Elashoff R, Morton DL. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol. 1999;6:705-711.
4. Burden AD, Newell J, Andrew N, Kavanagh G, Connor JM, Mackie RM. Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol. 1999;135:261-265.
5. Giles G, Staples M, McCredie M, Coates M. Multiple primary melanomas: an analysis of cancer registry data from Victoria and New South Wales. Melanoma Res. 1995;5:433-438.
6. Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary melanoma among melanoma survivors. Cancer. 2003;97:639-643.
7. Moseley HS, Giuliano AE, Storm FK, Clark WH, Robinson DS, Morton DL. Multiple primary melanoma. Cancer. 1979;43:939-944.
8. Marghoob AA, Slade J, Kopf AW, Salopek TG, Rigel DS, Bart RS. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypicalmole syndrome. Br J Dermatol. 1996;135:704-711.
9. Johnson TM, Hamilton T, Lowe L. Multiple primary melanomas. J Am Acad Dermatol. 1998;39:422-427.
10. Ariyan S, Poo W-J, Bolognia J, Buzaid A, Ariyan T. Multiple primary melanomas: data and significance. Plast Reconstr Surg. 1995;96:1384-1389.
11. Wolff J, Wollina U. Second malignancies in melanoma patients in Thuringia. J Eur Acad Dermatol Venereol. 2000;14:479-483.
12. Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W. Multiple primary melanomas. J Am Acad Dermatol. 2001;44:22-27.
13. Kang S, Barnhill RL, Mihn MC Jr, Sober AJ. Multiple primary cutaneous melanoma. Cancer. 1992;70:1911-1916.
14. Slingluff CL, Vollmer RT, Seigler HF. Multiple primary melanoma: incidence and risk factors in 283 patients. Surgery. 1993;113:330-339.
15. Titus-Ernstoff L, Duray PH, Ernstoff MS, Barnhill RL, Horn PL, Kirkwood JM. Dysplastic nevi in association with multiple primary melanoma. Cancer Res. 1988;48:1016-1018.
16. Titus-Ernstoff L, Perry AE, Spencer SK, Gibson JJ, Cole BF, Ernstoff MS. Pigmentary characteristics and moles in relation to melanoma risk. Int J Cancer. 2005;116:144-149.
17. Nordlund JJ, Kirkwood J, Forget BM, et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res. 1985;45:1855-1861.
18. Breslow NE, Day NE, eds. Statistical Methods in Cancer Research Vol II: The Design and Analysis of Cohort Studies. Lyon, France: International Agency for Research on Cancer; 1987. IARC Scientific Publication No. 82.
19. Burden AD, Vestey JP, Sirel JM, Aitchison TC, Hunter JAA, MacKie RM. Multiple primary melanoma: risk factors and prognostic implications. BMJ. 1994;309:375-377.
20. Savoia P, Quaglino P, Verrone A, Bernengo MG. Multiple primary melanomas: analysis of 49 cases. Melanoma Res. 1998;8:361-366.
21. Titus-Ernstoff L, Ernstoff MS, Kirkwood JM, Barnhill RL, Fine J, Duray PH. Usefulness of frequent skin examination for the early detection of second primary cutaneous melanoma. Cancer Detect Prev. 1989;13:317-321.
22. Blackwood MA, Holmes R, Synnestvedt M, et al. Multiple primary melanoma revisited. Cancer. 2002;94:2248-2255.
23. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97:195-199.
24. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 2002;288:321-333.
25. Shumaker SA, Legault C, Rapp SR, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291:2947-2958.